Newborn Screening Market Size, Share, Forecast Report 2032

Newborn Screening Market: Industry Perspective

The global newborn screening market size was worth around USD 845.31 million in 2023 and is predicted to grow to around USD 1634.27 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.6% between 2024 and 2032. The report analyzes the global newborn screening market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the newborn screening industry.

Request Free Sample

Newborn Screening Market: Overview

Newborn screening is a preventive pediatric screening test usually performed to diagnose any inborn abnormalities or congenital metabolism defects. Normally, newborns are more susceptible to infections, which can arise at any time, even from the first day of their lives. These newborn screening tests help physicians in the early detection of serious genetic disorders, which can result in a lifetime of disability if not treated at the right time. Newborn screening helps physicians to start the treatment from the initial stage, once the disease is diagnosed to reverse its prognosis. Early diagnosis and treatment help in the subsequent reduction of associated disabilities. These newborn programs differ from country to country, depending on the prevalence rate of different diseases and legal requirements for screening tests.

Newborn Screening Market: Growth Factors

The global newborn screening market is mainly driven by the growing incidences of neonatal diseases, which is leading to the high demand for newborn screening tests. Initiatives by the government in creating awareness about neonatal hereditary diseases are further boosting the newborn screening market growth globally. Technological advancements and growth in funding from government organizations are also propelling this market. Additionally, companies are also engaging in partnerships and collaborations to extend their product offerings, to increase their market shares and expand operations. These partnerships and collaborations are helping enhance the R&D capabilities for manufacturing innovative devices to meet different consumer needs. In 2015, for instance, Roche Diagnostics and Human Longevity entered into a collaboration of Roche Diagnostics' subsidiary Genentech's to conduct whole-genome sequencing on de-identified samples. The partnership helped Roche Diagnostics to discover new diagnostics and targeted therapies and analyze patient samples based on precise genetic categories. These collaborative activities are also fast-tracking drug discovery efforts, which can help detect chromosomal abnormalities in neonates and in the development of new therapies, thus further boosting the newborn screening market globally.

Newborn Screening Market: Segmentation

The study provides a decisive view of the newborn screening market by segmenting it based on the product, screening test, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By product, the market for newborn screening is divided into instruments and assay kits and reagents. The instruments segment is further classified into pulse oximeter, mass spectrometer, hearing screening devices, laparoscopes, retinoscopes, ultrasound machines, and others.

On the basis of screening test, the newborn screening market is fragmented into critical congenital heart disease, dry blood spot test, hearing screen, urine test, and other tests.

Based on end-user, the newborn screening market is divided into hospitals, clinics, and diagnostic centers.

Newborn Screening Market: Report Scope

Newborn Screening Market: Competitive Analysis

Some of the major players in the global newborn screening market include:

• Bio-Rad Laboratories
• GE Healthcare
• Thermo Fisher Scientific
• Agilent Technologies
• ZenTech
• Trivitron Healthcare
• PerkinElmer
• Natus Medical
• MP Biomedicals
• Medtronic

The global newborn screening market is segmented as follows;

Global Newborn Screening Market: By Product

• Instruments
  • Pulse Oximeter
  • Mass Spectrometer
  • Hearing Screening Devices
  • Laparoscopes
  • Retinoscopes
  • Ultrasound Machines
  • Others
• Assay Kits and Reagents

Global Newborn Screening Market: By Screening Test

• Dry Blood Spot Test
• Critical Congenital Heart Disease (CCHD)
• Hearing Screen
• Urine Test
• Other Tests

Global Newborn Screening Market: By End-User

• Hospitals
• Clinics
• Diagnostic Centers

Global Newborn Screening Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa